CRISPR-Cas Systems in Bacterial Pathogens: Emerging Tools for Therapeutic Development

Abstract: CRISPR-Cas systems have revolutionized the field of microbiology and genetic engineering, providing powerful tools for targeting bacterial pathogens. These adaptive immune mechanisms in bacteria serve not only as a defense against phage infections but also hold immense potential for therapeutic development. This review explores the intricate mechanisms of CRISPR-Cas systems, their classification, and their applications in combating antibiotic resistance and virulence in various bacterial pathogens. We highlight specific case studies demonstrating successful CRISPR interventions in bacteria such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. Additionally, we discuss delivery mechanisms for CRISPR components, the challenges of off-target effects, and the ethical considerations surrounding gene editing. With ongoing advancements in CRISPR technology and its integration with other therapeutic approaches, we envision a future where CRISPR-based therapies significantly enhance our ability to manage bacterial infections.